These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 6217074

  • 1. Diphosphonate bone scanning agents--current concepts.
    Fogelman I.
    Eur J Nucl Med; 1982; 7(11):506-9. PubMed ID: 6217074
    [Abstract] [Full Text] [Related]

  • 2. Skeletal scintigraphy with technetium diphosphonate in multiple myeloma--a comparison with skeletal x-ray.
    Lindström E, Lindström FD.
    Acta Med Scand; 1980; 208(4):289-91. PubMed ID: 6449830
    [Abstract] [Full Text] [Related]

  • 3. A radiopharmaceutical and clinical comparison of 99mTc-Sn-hydroxymethylene diphosphonate with 99mTc-Sn-hydroxyethylidene diphosphonate.
    Silberstein EB.
    Radiology; 1980 Sep; 136(3):747-51. PubMed ID: 6773104
    [Abstract] [Full Text] [Related]

  • 4. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
    Subramanian G, McAfee JG, Thomas FD, Feld TA, Zapf-Longo C, Palladino E.
    Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
    [Abstract] [Full Text] [Related]

  • 5. Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication.
    Rudd TG, Allen DR, Smith FD.
    J Nucl Med; 1979 Aug; 20(8):821-6. PubMed ID: 120422
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer.
    Coleman RE, Meier CA, Rubens RD, Fogelman I.
    Nucl Med Commun; 1988 Jul; 9(7):481-5. PubMed ID: 3173907
    [Abstract] [Full Text] [Related]

  • 7. Improved lesion detection with dimethyl-amino-diphosphonate: a report of two cases.
    Smith ML, Martin W, McKillop JH, Fogelman I.
    Eur J Nucl Med; 1984 Jul; 9(11):519-20. PubMed ID: 6240401
    [Abstract] [Full Text] [Related]

  • 8. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA, Tofe AJ, Benedict JJ, Francis MD, Barnett BL.
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [Abstract] [Full Text] [Related]

  • 9. Diphosphonates in the evaluation of metabolic bone disease.
    Fogelman I, Smith ML.
    Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
    [Abstract] [Full Text] [Related]

  • 10. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications.
    Tan KF, Chang CH.
    Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate].
    Otsuka N, Yoneda M, Sawai M, Saito J, Nagai K, Muranaka A, Terashima H, Yanagimoto S, Ito Y.
    Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135
    [No Abstract] [Full Text] [Related]

  • 12. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I, Pearson DW, Bessent RG, Tofe AJ, Francis MD.
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [Abstract] [Full Text] [Related]

  • 13. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
    Godart G, Durez M, Bevilacqua M, Abramovici J, Robience Y.
    Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
    [Abstract] [Full Text] [Related]

  • 14. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U, Kleinhans E, Zorn-Bopp E, Reuschel W, Muenzing W, Moser EA, Seiderer M.
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [Abstract] [Full Text] [Related]

  • 15. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA, Tofe AJ, Benedict JJ, Francis MD, Barnett BL.
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [Abstract] [Full Text] [Related]

  • 16. Scintigraphic evaluation of primary bone tumors. Comparison of technetium-99m phosphonate and gallium citrate imaging.
    Simon MA, Kirchner PT.
    J Bone Joint Surg Am; 1980 Jul; 62(5):758-64. PubMed ID: 6446566
    [Abstract] [Full Text] [Related]

  • 17. Clinical evaluation of a technetium-99m bone imaging agent based on the vicinal diphosphonate 1,2-diphosphonoethyleneglycol (DPEG).
    Pauwels EK, Camps JA, Blom J, Hermans J, Kelly JD, Cumming SA, Blackburn GM, Rashid A.
    Nucl Med Commun; 1985 Nov; 6(11):739-45. PubMed ID: 3831848
    [Abstract] [Full Text] [Related]

  • 18. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
    Knop J, Stritzke P, Kröger E, Schneider C, Wasmus G.
    Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
    [Abstract] [Full Text] [Related]

  • 19. Reaction of 99mTc-diphosphonate with N-donor ligands.
    Johannsen B.
    Int J Appl Radiat Isot; 1982 Jun; 33(6):429-32. PubMed ID: 6286510
    [No Abstract] [Full Text] [Related]

  • 20. What do we want from a bone-scanning agent?
    Fogelman I, Bessent RG.
    J Nucl Med; 1980 Mar; 21(3):296. PubMed ID: 6445001
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.